[1] Stasi C, Silvestri C, Voller F, et al. Epidemiology of liver cirrhosis[J]. J Clin Exp Hepatol, 2015,5(3):272. [2] Wree A, Broderick L, Canbay A, et al. From NAFLD to NASH to cirrhosis-new insights into disease mechanisms[J]. Nat Rev Gastroenterol Hepatol, 2013,10(11):627-636. [3] Habibullah M, Jemmieh K, Ouda A, et al. Metabolic-associated fatty liver disease: a selective review of pathogenesis, diagnostic approaches, and therapeutic strategies[J]. Front Med (Lausanne), 2024,11:1291501. [4] Younossi Z M, Koenig A B, Abdelatif D, et al. Global epidemiology of nonalcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence, and outcomes[J]. Hepatology, 2016,64(1):73-84. [5] Angulo P. Long-term mortality in nonalcoholic fatty liver disease: is liver histology of any prognostic significance?[J]. Hepatology, 2010,51(2):373-375. [6] Siddiqui M S, Fuchs M, Idowu M O, et al. Severity of nonalcoholic fatty liver disease and progression to cirrhosis are associated with atherogenic lipoprotein profile[J]. Clin Gastroenterol Hepatol, 2015,13(5):1000-1008.e3. [7] 丁玉平, 李海, 张文, 等. ALT升高的非酒精性脂肪性肝病的流行病学特征及其危险因素分析[J]. 临床肝胆病杂志, 2017, 33(12):2355-2360. [8] 尤红, 王福生, 李太生, 等. 慢性乙型肝炎防治指南(2022年版)[J]. 传染病信息, 2023,36(1):1-17. [9] 范建高. 中国非酒精性脂肪性肝病诊疗指南(2010年修订版)[J]. 中国医学前沿杂志(电子版), 2012,4(7):4-10. [10] 陆东东, 吴金明, 谢敏, 等. 不同饮酒量对脂肪肝患者肝功能和糖代谢的影响[J]. 温州医科大学学报, 2018,48(1):38-41+45. [11] Day C P. Natural history of NAFLD: remarkably benign in the absence of cirrhosis[J]. Gastroenterology, 2005,129(1):375-378. [12] Sherif Z A, Saeed A, Ghavimi S, et al. Global epidemiology of nonalcoholic fatty liver disease and perspectives on US minority populations[J]. Dig Dis Sci, 2016,61(5):1214-1225. [13] Starley B Q, Calcagno C J, Harrison S A. Nonalcoholic fatty liver disease and hepatocellular carcinoma: a weighty connection[J]. Hepatology, 2010,51(5):1820-1832. [14] 袁婧, 张连峰. 平均血小板体积联合FIB-4指数对非酒精性脂肪性肝硬化预后的评估价值[J]. 中国现代医生, 2022,60(9):38-42+46. [15] 杨发, 冯燕霞, 马成虎. 肝硬化患者血小板参数、凝血功能及D-二聚体变化与Child-Pugh肝功能分级的关系[J]. 临床消化病杂志, 2016,28(6):376-378. [16] 农远志. 肝硬化患者血小板参数、凝血功能及D-二聚体变化与Child-Pugh肝功能分级的关系[J]. 中国实验诊断学, 2017,21(10):1782-1784. [17] Hamaguchi M, Kojima T, Takeda N, et al. The metabolic syndrome as a predictor of nonalcoholic fatty liver disease[J]. Ann Intern Med, 2005,143(10):722-728. [18] Decaux G. Uric acid level in cirrhosis[J]. J Clin Gastroenterol, 2000,30(4):446-447. [19] 张代民, 崔庆, 许会彬, 等. 血清尿酸检测在肝硬化中的意义[J]. 临床肝胆病杂志, 2007,(4):266-267. [20] 刘沁雨, 常越, 张青, 等. 血清尿酸对非酒精性脂肪性肝病进展期肝纤维化/肝硬化的诊断价值[J]. 中国肝脏病杂志(电子版), 2020,12(1):24-30. |